rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Doron Shorrer

Director

Company insider

Files Form 4 as: Director, Pluri.

In numbers

Trades disclosed
28
Buys
3
Sells
1
Bought
$30K
Sold
$19K
Companies
1
Companies where not an officer
1
First trade
17 Jan 2006
Last trade
20 Aug 2026
Last filed
24 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
PLUR PluriDirector · Biotechnology · last 20 Aug 20263 buys · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 Aug 2026filed 24 Aug 2026PLUR PluriBiotechnologySEC FORM 4 Code A—31,569 at $0.00filing
20 Aug 2026filed 24 Aug 2026PLUR PluriBiotechnologySEC FORM 4 Code A—31,569 at $0.00filing
10 Sep 2020filed 10 Sep 2020PLUR PluriBiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
8 Apr 2019filed 8 Apr 2019PLUR Plurioption or derivative · BiotechnologySEC FORM 4 Code P—14,286 at $0.00filing
8 Apr 2019filed 8 Apr 2019PLUR PluriBiotechnologySEC FORM 4 Bought$10K14,286 at $0.70filing
19 Dec 2018filed 20 Dec 2018PLUR PluriBiotechnologySEC FORM 4 Code A—63,375 at $0.00filing
19 Dec 2018filed 20 Dec 2018PLUR PluriBiotechnologySEC FORM 4 Code A—49,875 at $0.00filing
14 Dec 2017filed 14 Dec 2017PLUR PluriBiotechnologySEC FORM 4 Code A—133,000 at $0.00filing
29 Dec 2016filed 29 Dec 2016PLUR PluriBiotechnologySEC FORM 4 Code A—66,500 at $0.00filing
30 May 2016filed 6 Jun 2016PLUR PluriBiotechnologySEC FORM 4 Sold$19K12,346 at $1.52filing
15 Feb 2016filed 17 Feb 2016PLUR PluriBiotechnologySEC FORM 4 Bought$10K12,346 at $0.81filing
5 Jan 2016filed 7 Jan 2016PLUR PluriBiotechnologySEC FORM 4 Code A—49,000 at $0.00filing
8 Jan 2015filed 8 Jan 2015PLUR PluriBiotechnologySEC FORM 4 Code A—49,000 at $0.00filing
26 Dec 2013filed 26 Dec 2013PLUR PluriBiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
27 Jun 2013filed 27 Jun 2013PLUR PluriBiotechnologySEC FORM 4 Code A—85,000 at $0.00filing
21 Dec 2011filed 22 Dec 2011PLUR PluriBiotechnologySEC FORM 4 Code A—125,000 at $0.00filing
18 May 2011filed 19 May 2011PLUR PluriBiotechnologySEC FORM 4 Code A—42,860 at $0.00filing
7 Dec 2010filed 7 Dec 2010PLUR PluriBiotechnologySEC FORM 4 Bought$9,8007,000 at $1.40filing
28 Oct 2010filed 1 Nov 2010PLUR PluriBiotechnologySEC FORM 4 Code A—80,000 at $0.00filing
10 May 2010filed 17 May 2010PLUR PluriBiotechnologySEC FORM 4 Code A—3,648filing

News

Head to Head Comparison: Cytokinetics (NASDAQ:CYTK) vs. Pluri (NASDAQ:PLUR)PLUR · themarketsdaily.com · 10 Oct 2026

0 headlines in the last 90 days name Doron Shorrer; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care4

Buys in green, sells in red, by the company’s sector.

Related people

Alexandre Weinstein ManieuDirector and 10% owner · Director and 10% owner at Pluri, filing Form 4 there in the last year